This video examines second-line treatment options for non-muscle invasive bladder cancer patients who relapse after BCG therapy and are not eligible for radical cystectomy.
James M. McKiernan, MD
Advertisement
Articles by James M. McKiernan, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
What Are The Biggest Misconceptions About CAR T Cells in Multiple Myeloma?
2
Blood-Based Lung Cancer Screening Tool Earns FDA Breakthrough Device Status
3
FDA Approves Iberdomide Combo in Relapsed/Refractory Multiple Myeloma
4
Defining the Objectives of an Analysis of Tarlatamab in Brain Metastases
5